TP53 and lymphoma: Genomic data acquired from over 20,000 patients have confirmed that TP53 is the most predominant mutated gene in all human malignancies [12, 33–35], such as lymphoma [15], hepatocellular carcinoma [36, 37], colorectal cancer [38], and mucosal melanoma [39].